ID: ALA4759231

Max Phase: Preclinical

Molecular Formula: C13H9NO6

Molecular Weight: 275.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=c1c2cc(O)c(O)c(O)c2[nH]c2cc(O)cc(O)c12

Standard InChI:  InChI=1S/C13H9NO6/c15-4-1-6-9(7(16)2-4)11(18)5-3-8(17)12(19)13(20)10(5)14-6/h1-3,15-17,19-20H,(H,14,18)

Standard InChI Key:  OABKNXPPQWGEBD-UHFFFAOYSA-N

Associated Targets(non-human)

Trichophyton rubrum 3646 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 275.22Molecular Weight (Monoisotopic): 275.0430AlogP: 1.21#Rotatable Bonds: 0
Polar Surface Area: 134.01Molecular Species: NEUTRALHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.46CX Basic pKa: CX LogP: 3.33CX LogD: 3.03
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.27Np Likeness Score: 1.32

References

1. Rząd K,Paluszkiewicz E,Gabriel I.  (2021)  A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance.,  35  [PMID:33486051] [10.1016/j.bmcl.2021.127815]

Source